IFNG and neoplasm: IFN-γ release stimulates cancer stem cells (CSCs) to upregulate MHC class I molecules and intercellular cell adhesion molecule-1(ICAM-1), enhancing CD8+ T cell-mediated cytotoxicity against tumor cells (72, 73).